Quality Use of Medicine in Aged Care Homes
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (30 November 2019) | Viewed by 10827
Interests: quality use of medicines; aged care; medication safety; pharmacists in aged care; pharmacists in general practice; medication adherence; pharmacoeconomics; pharmacy education; health service optimisation
The number of people older than 65 years will rise to approximately 16% of the world population by 2050. This ageing population has produced increased demand on the healthcare system, resulting in an increased number of people receiving residential aged care services. Older adults residing in aged care homes are often diagnosed with multiple chronic diseases and require multiple medications to manage their health‐related conditions. The majority of residents in aged care homes are exposed to polypharmacy that places them at a higher risk of drug interactions, adverse drug reactions, and medication errors, and increases morbidity, mortality, and complexity of care.
Recent studies report a concerning rate of medication-adverse events in aged care homes, the causes of which are likely to be multifactorial. Besides polypharmacy, other important factors that are responsible for medication-adverse events and play roles in the quality use of medicine in aged care homes include nursing staff education; aged care homes medication management policies and procedures; the extent of interdisciplinary collaboration between the service providers; and access to health professionals such as GPs, pharmacists, and specialists.
This Special Issue aims to share findings on different aspects of the quality use of medicine in aged care homes including
- the scope, impact, and spread of the issue
- strategies to improve the medication management system
- interventions resulting in optimising medications
- interprofessional practice
- the impact of collaborative pharmacists/pharmacy services and
- training and education
Dr. Sam Kosari
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- quality use of medicine
- aged care home
- nursing home
- long-term care facilities
- medication management system
- medication optimization
- medication review
- interprofessional practice